big G

H2 - Implements a structured low-dose CT screening program

H3 - Implements a structured low-dose CT screening program that adheres to NCCN, USPSTF, or CMS criteria

H4 - Implements a structured low-dose CT screening program that adheres to NCCN, USPSTF, or CMS criteria and uses a standardized process

H5 - Implements a structured low-dose CT screening program that adheres to NCCN, USPSTF, or CMS criteria and uses a standardized process to manage patient follow-through
H6 - Implements a structured low-dose CT screening program that adheres to NCCN, USPSTF, or CMS criteria and uses a standardized process to manage patient follow-through
  • Heading widgets with H2 – H6 levels and default style.

This is a paragraph. It contains many different, sometimes useful, HTML5 tags. Of course there are classics like emphasis, strong, and small but there are many others as well. Hover the following text for abbreviation tag: abbr. Similarly, you can use acronym tag like this: ftw. You can define deleted text which often gets replaced with inserted text.

You can also use keyboard text, which sometimes is styled similarly to the <code> or samp tags. Even more specifically, there is a tag just for variables. Not to be mistaken with blockquotes below, the quote tag lets you denote something as quoted text. Lastly don’t forget the sub (H2O) and sup (E = MC2) tags.

This is an aside.


Blockquote: I quickly explained that many big jobs involve few hazards

This is a mult-line blockquote with a cite reference. People think focus means saying yes to the thing you’ve got to focus on. But that’s not what it means at all. It means saying no to the hundred other good ideas that there are. You have to pick
carefully. I’m actually as proud of the things we haven’tdone as the things I have done. Innovation is saying no to 1,000 things.
Steve Jobs – Apple Worldwide Developers’ Conference, 1997


Tables can have captions now.
Person Number Third Column
Someone Lastname 900 Nullam quis risus eget urna mollis ornare vel eu leo.
Person Name 1200 Vestibulum id ligula porta felis euismod semper. Donec ullamcorper nulla non metus auctor fringilla.
Another Person 1500 Vivamus sagittis lacus vel augue laoreet rutrum faucibus dolor auctor. Nullam id dolor id nibh ultricies vehicula ut id elit.
Last One 2800 Morbi leo risus, porta ac consectetur ac, vestibulum at eros. Cras mattis consectetur purus sit amet fermentum.

Definition List Title
Definition list division.
Kitchen Sink
Used in expressions to describe work in which all conceivable (and some inconceivable) sources have been mined. In this case, a bunch of markup.
aside
Defines content aside from the page content
blockquote
Defines a section that is quoted from another source

  • Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vivamus lacinia odio vitae vestibulum vestibulum.
    • Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.
    • Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.
  • Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur arcu erat, accumsan id imperdiet et, porttitor at sem.
    • Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos.
    • Qui ratione voluptatem sequi nesciunt, neque porro quisquam est, qui dolorem ipsum quia dolor sit amet.

  1. Praesent sapien massa, convallis a pellentesque nec, egestas non nisi. Mauris blandit aliquet elit.
    1. Et harum quidem rerum facilis est et expedita distinctio. Nam libero tempore, cum soluta nobis est eligendi optio.
    2. Cumque nihil impedit quo minus id quod maxime placeat facere possimus, omnis voluptas assumenda est.
  2. Donec sollicitudin molestie malesuada. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
    1. Temporibus autem quibusdam et aut officiis debitis aut rerum necessitatibus saepe eveniet ut et voluptates repudiandae.
    2. Itaque earum rerum hic tenetur a sapiente delectus, ut aut reiciendis voluptatibus maiores alias consequatur aut.

1 Infinite Loop
Cupertino, CA 95014
United States

Since 2010, we have been building a collaborative network to share expertise, precious resources, and transcend barriers to solve the challenges facing the lung cancer community

Heading text accepts BR and SPAN html elements for inline decoration and formatting. Highlight blue text with the go2-blue-text css class.

Blue/green

Preset: Grn Lg/Sm

Blue/green/outline hover

Preset: Grn Hover Outline Lg/Sm

Green/outline

Preset: Grn Outline Lg/Sm

Green/blue

Preset: Blu Lg/Sm

Blue/green/outline hover

Preset: Blu Hover Outline Lg/Sm

Blue/outline

Preset: Blu Outline Lg/Sm

  • Use Button presets in widget controls
  • Add css class go2-btn-wide for full-width button
#go2_accordion_1
#go2_accordion_2
#go2_accordion_3
Is there a cost to become a COE?
No. There is no charge for the application and designation process.
Can any healthcare facility apply?
Yes, any facility that meets the criteria for one or more designations is welcome to apply. COE-designated facilities include small and large, rural and urban, private and government-run, academic and non-teaching.
What if my application is not approved?
The application process is intended to be collaborative and empowering. It is not uncommon for a facility to begin the application process and discover they still need to strengthen some aspects of their program in order to meet the eligibility criteria. GO2 will work with you to identify strategies and peer support opportunities to advance your program and reach your designation goal(s).
How do I maintain my COE Designations?
Each year you will need to submit program data that will report program metrics that indicate your facility has continued to meet and maintain the requirements for the awarded designations. Any requested data will be aggregated, outcome-level data, not patient-level. This process is not meant to be punitive; we welcome any program having difficulty meeting the requirements to inform GO2 so we can help problem-solve.
What resources does GO2 provide to help develop and grow our Center of Excellence?
We offer many program development, networking, and promotional tools. These include personalized technical assistance and support from GO2, access to the Lung Cancer Patient Registry’s aggregated data, promotional seals to use at your facility and online, and inclusion in the COE national directory. Learn more about the benefits of becoming a COE here.
Is there a cost to become a COE?
No. There is no charge for the application and designation process.
Can any healthcare facility apply?
Yes, any facility that meets the criteria for one or more designations is welcome to apply. COE-designated facilities include small and large, rural and urban, private and government-run, academic and non-teaching.
What if my application is not approved?
The application process is intended to be collaborative and empowering. It is not uncommon for a facility to begin the application process and discover they still need to strengthen some aspects of their program in order to meet the eligibility criteria. GO2 will work with you to identify strategies and peer support opportunities to advance your program and reach your designation goal(s).
Can any healthcare facility apply?
Yes, any facility that meets the criteria for one or more designations is welcome to apply. COE-designated facilities include small and large, rural and urban, private and government-run, academic and non-teaching.
What if my application is not approved?
The application process is intended to be collaborative and empowering. It is not uncommon for a facility to begin the application process and discover they still need to strengthen some aspects of their program in order to meet the eligibility criteria. GO2 will work with you to identify strategies and peer support opportunities to advance your program and reach your designation goal(s).
How do I maintain my COE Designations?
Each year you will need to submit program data that will report program metrics that indicate your facility has continued to meet and maintain the requirements for the awarded designations. Any requested data will be aggregated, outcome-level data, not patient-level. This process is not meant to be punitive; we welcome any program having difficulty meeting the requirements to inform GO2 so we can help problem-solve.
What resources does GO2 provide to help develop and grow our Center of Excellence?
We offer many program development, networking, and promotional tools. These include personalized technical assistance and support from GO2, access to the Lung Cancer Patient Registry’s aggregated data, promotional seals to use at your facility and online, and inclusion in the COE national directory. Learn more about the benefits of becoming a COE here.

Lung Cancer Screening

Implements a structured low-dose CT screening program that adheres to NCCN, USPSTF, or CMS criteria and uses a standardized process to manage patient follow-through.

Qualifying criteria:

  • Screen according to CMS, NCCN, USPSTF criteria; if your program screens patients outside these established criteria, please share your process for identifying patients’ screening appropriateness and which additional risk factors are considered for screening eligiblity.
  • A patient-centered discussion (about the benefits and harms) occurs before or at the time of low dose CT screening–for every baseline screening at a minimum.
  • Adherence to standards based on best-published practices for controlling screening quality, radiation dose and diagnostic procedures as outlined by American College of Radiology (ACR) Practice Parameters.
  • Utilize structured reporting and standardized follow-up and management decisions based on current, established screening classification systems and management algorithms.
    (LungRADS, NCCN Clinical Guidelines, ELCAP)
  • Consult with or refer to a lung cancer multidisciplinary* and cancer care team for the management of any concerning findings (thoracic or extra-thoracic) in the screening process.
    *Multidisciplinary is defined as and must include at least 3 lung cancer disciplines from among the following: thoracic surgery, pulmonology, interventional pulmonology, interventional radiology, chest radiology, medical oncology, radiation oncology, pathology, advanced practice providers, navigator; if my referral, must explain the patient care referral pathway.
  • Integrate a standardized process within the screening workflow for patient and referring provider/care team communication on screening results and management plan.
  • Ask about current smoking status, and advise to quit, provide, or refer for cessation services.
    (USPSTF, CMS)
  • Utilize a process for tracking, measuring, and reconciliation of annual and interval follow-up adherence in screening.
  • Collect and review internal clinical outcomes in a quality improvement process.

Best practice recommendations:

  • Submission of LDCT screening data to a multi-site registry (e.g., ACR LCSR, IELCAP, or other).
  • Monitor for lung cancer stage shift impact from screen-detected lung cancers.

 

Apply now

Incidental Pulmonary Nodules

Provides a structured program that captures incidentally found lung nodules from imaging. Utilizes standardized processes for patient follow-up and reporting across the health system.

Qualifying criteria:

  • Structured nodule reporting in place for standardized follow-up and management decisions based on appropriate and established nodule classification systems and management guidelines.
    (Fleischner Criteria, LungRADS, ELCAP, NCCN)
  • Consult with or refer to a lung cancer multidisciplinary* and cancer care team for the management of any concerning findings.
    *Multidisciplinary is defined as and must include at least 3 lung cancer disciplines from among the following: thoracic surgery, pulmonology, interventional pulmonology, interventional radiology, chest radiology, medical oncology, radiation oncology, pathology, advanced practice providers, navigator; if by referral, must explain the patient care referral pathway.
  • Commitment to a standardized process for communication with patients and their active care providers about test results and management plan.
  • Ask about current smoking status, advise to quit, provide, or refer for cessation services.
  • Adherence to standards based on published best practices for controlling image quality, as low as reasonably achievable radiation dose, and diagnostic procedures as outlined by the American College of Radiology.
  • Tracking, measuring, and reconciliation process for interval follow-up adherence for incidentally detected lung nodules based on patient risk for lung cancer and surveillance guidelines.
    (Fleischner Criteria, LungRADS, ELCAP, NCCN)
  • Internal clinical outcomes review and quality improvement process.

Best practice recommendations:

  • Institutional workflows that capture (at all entry points into the health system) and refer incidental pulmonary nodules for management.
  • Institutional tools are engaged to ensure all IPNs are identifed and managed.

 

Apply now

Multidisciplinary Teams

Provides a patient-centric multidisciplinary team comprised of a cancer navigator, or coordinator, and a minimum of three lung cancer disciplines that meet at a regularly scheduled tumor board.

Qualifying criteria:

  • Regularly scheduled MDT or Tumor/Nodule Board (and more frequently if needed) meetings.
  • MDT comprised of a minimum of 3 lung cancer disciplines (thoracic surgery, pulmonology, interventional pulmonology, interventional radiology, chest radiology, medical oncology, radiation oncology, pathology,
    advanced practice providers, navigator).
  • Patient-centered communication and coordination of information for expeditious clinical decision-making and care routinely occurs following MDT and/or Tumor/Nodule Board review.

Best practice recommendations:

  • Designated lung cancer navigator engaged in the clinical care continuum for all lung cancer screening and cancer patients.
  • Virtual MDT is available and will be accessed in the absence of local MDT resources.

 

Apply now

Cancer Care

Demonstrates access to standard cancer services within medical, radiation, and surgical oncology and pathology.

Qualifying criteria:

  • A patient-centered discussion about the potential benefits and harms of lung cancer treatment occurs at each point of the patient’s cancer care journey.
  • Biomarker Testing: Access to and compliance with guideline-directed testing for molecular and immune biomarkers with NGS technology in all patients with guideline-eligible tumors (when clinically appropriate).
    Using NGS results, consistently identify actionable mutations and eligiblity for guideline-directed targeted therapies or immunotherapies.
    (NCCN, ASCO, CAP)
  • Medical Oncology: Compliance with practice standards for the diagnostic workup, staging, and medical oncology (disease specific) treatment of all lung cancer types based on evidence, expert consensus, and practice guidelines for cancer care and treatment.
    (TNM Stage Classification for Lung Cancer, ACCP, NCCN, ASCO, ESMO, SITC)
  • Radiation Oncology: Compliance with practice standards for the diagnostic workup, staging, and radiation treatment of all lung cancer types based on evidence, expert consensus, and practice guidelines for cancer care and treatment.
    (TNM Stage Classification for Lung Cancer, ASTRO, NCCN, ESTRO)
  • Thoracic Oncology: Compliance with practice standards for the diagnostic workup, staging, and surgical treatment of all lung cancer types based on evidence, expert consensus, and practice guidelines for cancer care and treatment.
    (AATS, ACCP, ESMO, NCCN, SOS, STS, TNM Stage Classification for Lung Cancer)
  • Pathology: Comply with practice standards based on evidence, expert consensus, and practice guidelines for pathologic evaluation of malignancies.
    (CAP, AMP, ASCO, NCCN)
  • Actively engage or have access to multidisciplinary expert input by way of tumor board or other team-based mechanism, including virtual.
  • Commitment and care delivery mechanisms are in place that standardizes consistent communication with patients and their active care providers about test results, diagnostic workup, and management plan.
  • Contribute to aggregated collection of relevant data and report to a cancer registry.
    (hospital, central or state, or special purpose registry, NPCR, NCI, SEER)
  • Ask about current smoking status and, as appropriate, advise to quit, provide, or refer for cessation services.
    (USPSTF, CMS)

Best practice recommendations:

  • Internal clinical outcomes review and quality improvement process
  • Thoracic Oncologist(s) are board certified thoracic or cardio-thoracic surgeons.

 

Apply now

Biomarker Testing

Ensures access to guideline-directed testing for molecular and immune biomarkers with next generation sequencing technology in all patients with guideline-eligible tumors to determine eligibility for targeted therapies or immunotherapies.

Qualifying criteria:

  • Access to guideline-directed testing for molecular and immune biomarkers with NGS technology in all patients with guideline eligible tumors (when clinically appropriate) to determine eligibility for targeted therapies or immunotherapies.
  • Biomarker and PD-L1 results are reviewed and discussed with patients once results are available. Discussion includes the clinical implications and therapeutic options based on these results.
  • Biomarker and PD-L1 results are reviewed and discussed with patients once results are available. Discussion includes the clinical implications and therapeutic options based on these results.
  • When appropriate, guideline directed PD-L1 and biomarker testing are integrated into treatment decisions before systemic therapy is initiated.
  • In the setting of disease progression on FDA approved therapy, updated PD-L1 and biomarker testing is utilized to identify next therapeutic option.
  • In the setting of disease progression, updated PD-L1 and biomarker testing is utilized to confirm need for clinical trial referral when FDA approved therapeutics are not an option.

Best practice recommendations:

  • Rapid on-site evaluation (ROSE), when available to increase diagnostic and molecular yield.
  • Utilization of liquid biopsy modalities in the setting of tissue insufficiency or unavailability and points of disease progression.

 

Apply now

Smoking Cessation

Consistently supplies evidence-based smoking cessation services and information across the lung cancer care continuum.

Qualifying criteria:

  • 5 A’s (Ask, Advise, Assess, Assist, Arrange) are consistently integrated across the cancer care continuum in initial and follow-up visits.
  • Evidence-based smoking cessation services are consistently integrated across the cancer care continuum in initial and follow-up visits.
  • When clinically indicated and appropriate, FDA-approved pharmacotherapy (OTC and prescription) options are offered and prescribed to patients.
  • Behavioral therapy modalities (individual counseling, motivational interviewing, group counseling, cognitive behavioral therapy) are offered and provided (in-person, telehealth, or telephonic) to patients as accepted.

Best practice recommendations:

  • Actively engage in use of text messaging, app and/or web-based activities, and/or print materials for cessation work.
  • Proactively address stigma and people-first communication to destigmatize lung cancer, build trust, and promote communication.

 

Apply now

Survivorship

Facilitates survivorship care plans and resources to improve quality of life among all lung cancer patients.

Qualifying criteria:

  • Lung cancer patient care is a shared and coordinated effort by oncology, primary care, and subspecialty providers.
    (OCS, NCCN, COC)
  • All lung cancer survivors should be assessed annually or more frequently to determine any needs and necessary interventions related to their cancer.
    (NCCN)
  • Survivorship Program exists to meet the needs of lung cancer patients with curative intent.
    (OCS, NCCN, COC)
  • Screening for psychosocial and mental health needs of lung cancer survivors occurs regularly. Treatment and support are offered as needed.
    (OCS, NCCN, COC)
  • Ask about current smoking status, and advise to quit, provide, or refer for cessation services.
    (USPSTF, CMS)
  • Healthy lifestyle and behaviors, and preventive health measures are offered and provided to all lung cancer survivors.
    (NCCN)

 

Apply now

Patient Centric Research

Consistently navigates lung cancer patients to clinical trial opportunities when appropriate.

Qualifying criteria:

  • Internal policy and procedures and clinical pathways are in place to consistently access and query ClinicalTrials.gov or another commensurate tool on behalf of patients.
  • Prompt referral to clinical trials when a disease has progressed and updated PD-L1 and biomarker testing confirm FDA-approved therapeutics are not an option.

Best practice recommendations:

  • Submission of LDCT screening data to a multi-site registry (e.g., ACR LCSR, IELCAP, or other).
  • Cancer Care facility is engaged, equipped, and open to supporting patients in local clinical research trial enrollment.
  • Cancer Care facility has a dedicated research team to support patient participation in clinical trials.
  • Promote awareness of research participation impact among the patient population.

 

Apply now

Health Equity

Consistently navigates lung cancer patients to clinical trial opportunities when appropriate.

Demonstrates an approach that considers diversity, health equity and inclusion for all community members.

This designation is coming soon!

 

Notify me

Community Engagement

Participates in community outreach to expand lung cancer awareness and education.

This designation is coming soon!

 

Notify me

All styles are set in the widget settings